Literature DB >> 16735620

Cessation of hormone replacement therapy after reports of adverse findings from randomized controlled trials: evidence from a British Birth Cohort.

Gita Mishra1, Helen Kok, Russell Ecob, Rachel Cooper, Rebecca Hardy, Diana Kuh.   

Abstract

OBJECTIVES: We examined the cessation of hormone replacement therapy (HRT) among British women, by educational level, social class, and cardiovascular risk factors, at the time of publicity about 2 clinical trials of HRT that were halted after adverse findings.
METHODS: A total of 1387 women aged 57 years reported their monthly HRT use between January 2002 and February 2003. A succession of regression-based time-series models were fitted to detect changes in the proportion of HRT users stratified by education level, social class, hypertension, and obesity.
RESULTS: The overall percentage of HRT users declined from 31% in January 2002 to less than 26% by February 2003. Changes in trends of HRT use were first detected in June 2002 (for women with advanced secondary educational qualification or higher) and in July 2002 (for all other groups). The rate of decline was greatest for women with no formal educational qualifications, from the manual social class, or who were hypertensive or obese.
CONCLUSIONS: These decreases coincided with the announced cessation of a large US clinical trial of HRT. This publicity may have had a differential influence on the immediate decline in HRT use by various groups of British women.

Entities:  

Mesh:

Year:  2006        PMID: 16735620      PMCID: PMC1483866          DOI: 10.2105/AJPH.2005.071332

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  18 in total

Review 1.  Misleading media reporting? The MMR story.

Authors:  Justin Lewis; Tammy Speers
Journal:  Nat Rev Immunol       Date:  2003-11       Impact factor: 53.106

2.  The life course prospective design: an example of benefits and problems associated with study longevity.

Authors:  M E J Wadsworth; S L Butterworth; R J Hardy; D J Kuh; M Richards; C Langenberg; W S Hilder; M Connor
Journal:  Soc Sci Med       Date:  2003-12       Impact factor: 4.634

3.  Misled and confused? Telling the public about MMR vaccine safety. Measles, mumps, and rubella.

Authors:  C J Clements; S Ratzan
Journal:  J Med Ethics       Date:  2003-02       Impact factor: 2.903

4.  Changes in use of hormone replacement therapy after the report from the Women's Health Initiative: cross sectional survey of users.

Authors:  Beverley Lawton; Sally Rose; Deborah McLeod; Anthony Dowell
Journal:  BMJ       Date:  2003-10-11

5.  The validity of self-reported use of hormone replacement therapy among Danish nurses.

Authors:  Ellen Leth Løkkegaard; Søren Påske Johnsen; Berit Lillienthal Heitmann; Claudia Stahlberg; Anette Tønnes Pedersen; Erik Bernhard Obel; Yrsa Andersen Hundrup; Jesper Hallas; Henrik Toft Sørensen
Journal:  Acta Obstet Gynecol Scand       Date:  2004-05       Impact factor: 3.636

Review 6.  Women's health in midlife: findings from a British birth cohort study.

Authors:  Diana Kuh; Rebecca Hardy
Journal:  J Br Menopause Soc       Date:  2003-06

7.  Effect of the Women's Health Initiative on women's decisions to discontinue postmenopausal hormone therapy.

Authors:  Bruce Ettinger; Deborah Grady; Anna N A Tosteson; Alice Pressman; Judith L Macer
Journal:  Obstet Gynecol       Date:  2003-12       Impact factor: 7.661

8.  Birthweight, childhood social class, and change in adult blood pressure in the 1946 British birth cohort.

Authors:  Rebecca Hardy; Diana Kuh; Claudia Langenberg; Michael E J Wadsworth
Journal:  Lancet       Date:  2003-10-11       Impact factor: 79.321

9.  National use of postmenopausal hormone therapy: annual trends and response to recent evidence.

Authors:  Adam L Hersh; Marcia L Stefanick; Randall S Stafford
Journal:  JAMA       Date:  2004-01-07       Impact factor: 56.272

10.  Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000.

Authors: 
Journal:  BJOG       Date:  2002-12       Impact factor: 6.531

View more
  6 in total

1.  Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control study.

Authors:  Millie D Long; Christopher F Martin; Joseph A Galanko; Robert S Sandler
Journal:  Am J Gastroenterol       Date:  2010-03-30       Impact factor: 10.864

2.  Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study.

Authors:  Ditte-Marie Bretler; Peter Riis Hansen; Steen Zabell Abildstrøm; Casper Haslund Jørgensen; Rikke Sørensen; Morten Lock Hansen; Tina Ken Schramm; Ellen Løkkegaard; Christian Torp-Pedersen; Gunnar Hilmar Gislason
Journal:  Br J Clin Pharmacol       Date:  2011-01       Impact factor: 4.335

3.  Menopause, Reproductive Life, Hormone Replacement Therapy, and Bone Phenotype at Age 60-64 Years: A British Birth Cohort.

Authors:  D Kuh; S Muthuri; R Cooper; A Moore; K Mackinnon; C Cooper; J E Adams; R Hardy; K A Ward
Journal:  J Clin Endocrinol Metab       Date:  2016-07-29       Impact factor: 5.958

4.  Differences in menopausal hormone therapy use among women in Germany between 1998 and 2003.

Authors:  Yong Du; Martina Dören; Hans-Ulrich W Melchert; Christa Scheidt-Nave; Hildtraud Knopf
Journal:  BMC Womens Health       Date:  2007-10-18       Impact factor: 2.809

5.  Age at menopause and lifetime cognition: Findings from a British birth cohort study.

Authors:  Diana Kuh; Rachel Cooper; Adam Moore; Marcus Richards; Rebecca Hardy
Journal:  Neurology       Date:  2018-04-11       Impact factor: 9.910

6.  Age at period cessation and trajectories of cardiovascular risk factors across mid and later life.

Authors:  Linda Marie O'Keeffe; Diana Kuh; Abigail Fraser; Laura D Howe; Debbie Lawlor; Rebecca Hardy
Journal:  Heart       Date:  2020-02-25       Impact factor: 5.994

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.